Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxMinority InterestNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Interparfums (IPAR) Cash & Equivalents (2016 - 2025)

Historic Cash & Equivalents for Interparfums (IPAR) over the last 16 years, with Q3 2025 value amounting to $110.4 million.

  • Interparfums' Cash & Equivalents rose 4077.71% to $110.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $110.4 million, marking a year-over-year increase of 4077.71%. This contributed to the annual value of $125.4 million for FY2024, which is 4179.31% up from last year.
  • Per Interparfums' latest filing, its Cash & Equivalents stood at $110.4 million for Q3 2025, which was up 4077.71% from $151.5 million recorded in Q2 2025.
  • In the past 5 years, Interparfums' Cash & Equivalents ranged from a high of $159.6 billion in Q4 2021 and a low of $21.0 million during Q1 2024
  • Its 5-year average for Cash & Equivalents is $8.5 billion, with a median of $104.7 million in 2022.
  • In the last 5 years, Interparfums' Cash & Equivalents soared by 9396651.3% in 2021 and then crashed by 9993.44% in 2022.
  • Interparfums' Cash & Equivalents (Quarter) stood at $159.6 billion in 2021, then tumbled by 99.93% to $104.7 million in 2022, then dropped by 15.52% to $88.5 million in 2023, then skyrocketed by 41.79% to $125.4 million in 2024, then decreased by 11.99% to $110.4 million in 2025.
  • Its Cash & Equivalents was $110.4 million in Q3 2025, compared to $151.5 million in Q2 2025 and $96.6 million in Q1 2025.